
Tuberculosis (TB) remains a worldwide emergency (8 million new cases per year, 2 million deaths annually) mostly affecting poor countries. To this old, persistent threat, a new emergency is adding further challenge, i.e., the multidrug-resistant TB, which in its extreme and highly lethal form is called XDR TB (extensively drug-resistant TB). How to fight XDR TB is a high research and public health priority.
Extensively Drug-Resistant Tuberculosis, Population Surveillance, Antitubercular Agents, Prevalence, Humans, Microbial Sensitivity Tests, Mycobacterium tuberculosis, Global Health, World Health Organization, Tuberculosis, Pulmonary
Extensively Drug-Resistant Tuberculosis, Population Surveillance, Antitubercular Agents, Prevalence, Humans, Microbial Sensitivity Tests, Mycobacterium tuberculosis, Global Health, World Health Organization, Tuberculosis, Pulmonary
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
